跳至主要内容
临床试验/JPRN-UMIN000016861
JPRN-UMIN000016861已完成未知

Analysis of effect of mosapride citrate administration on increasing in type 2 diabetic patient's postprandial plasma active glucagon-like peptide-1 - Effect of mosapride citrate in type 2 diabetic patient's GLP-1

Chiba University0 个研究点目标入组 16 人开始时间: 2015年3月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Type 1 diabetic patients 2) Patient with a history of diabetic coma within 6 months 3) Necessity of insulin such as severe infection, perioperative period, and severe external injury 4) Severe hepatic and renal disorder (Ccr < 30mL/min, serum Cre > 2.0 mg/dl (female), 2.5 mg/dl (male), Child-Pugh grade C) 5) Severe gastrointestinal dysfunction 6) Patient administrated drugs with the same indications of test drug or comparative drug, insulin GLP-1 analog, or DPP4 inhibitor, or treated by 4 or more diabetes drug 7) Pregnant female, lactating female, or female with possibility or planning of pregnancy 9) Patients evaluated incompetent by doctors in attendance

研究者

相似试验